Nucleic acid functionalized extracellular vesicles as promising therapeutic systems for nanomedicine
2022

Nucleic Acid Functionalized Extracellular Vesicles in Nanomedicine

publication Evidence: moderate

Author Information

Author(s): Liu Chunping, He Dongyue, Cen Huan, Chen Huiqi, Li Longmei, Nie Guangning, Zhong Zixue, He Qingfeng, Yang Xiaofei, Guo Sien, Wang Lei, Fan Zhijin

Primary Institution: State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

Hypothesis

Nucleic acid-functionalized extracellular vesicles (EVs) can enhance therapeutic systems in nanomedicine.

Conclusion

Nucleic acid-functionalized EVs show great potential as therapeutic systems in nanomedicine, particularly for drug delivery, gene therapy, and immunotherapy.

Supporting Evidence

  • Extracellular vesicles are natural carriers with excellent biocompatibility and unique biological functions.
  • Nucleic acids can enhance the targeting and therapeutic capabilities of extracellular vesicles.
  • Engineering strategies can improve the performance of nucleic acid-functionalized extracellular vesicles.

Takeaway

Scientists are using tiny bubbles called extracellular vesicles to carry medicine and genes into the body, which could help treat diseases better.

Methodology

This review summarizes the functions and mechanisms of nucleic acids in diagnosis and treatment, and discusses engineering strategies for nucleic acid-functionalized EVs.

Limitations

Challenges include low natural production rates of EVs, stability issues of RNA, and difficulties in clinical application.

Digital Object Identifier (DOI)

10.20517/evcna.2021.21

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication